Protara Therapeutics (NASDAQ:TARA) Now Covered by Cantor Fitzgerald
Cantor Fitzgerald initiated coverage on shares of Protara Therapeutics (NASDAQ:TARA – Free Report) in a report issued on Friday, MarketBeat reports. The firm issued an overweight rating on the stock. A number of other equities research analysts have also recently issued reports on the stock. Lifesci Capital assumed coverage on shares of Protara Therapeutics in […]
Cantor Fitzgerald initiated coverage on shares of Protara Therapeutics (NASDAQ:TARA – Free Report) in a report issued on Friday, MarketBeat reports. The firm issued an overweight rating on the stock. A number of other equities research analysts have also recently issued reports on the stock. Lifesci Capital assumed coverage on shares of Protara Therapeutics in […]
